TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

S J Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.